Found 7 matching trials
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases
PHASE2This pilot phase II trial studies how effective pembrolizumab and liver-dir...
Location
University of California, San Francisco
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)
PHASE2This is a Phase 2 peptide receptor radionuclide therapy trial of 90Y-DOTATO...
Location
University of Iowa Hospitals and Clinics
Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET
PHASE2Peptide Receptor Radionuclide Therapy (PRRT) is based on specific somatosta...
Location
Ospedale San Raffaele
Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression
PHASE2This is a non-randomized phase II , open label, comparative study. Patients...
Location
Centrum Diagnostyczno-Lecznicze Gammed
Combination Targeted Radiotherapy in Neuroendocrine Tumors
NAThe primary aim of this project is to determine, what fraction of individua...
Location
University of Iowa
Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor
EARLY_PHASE1This is a prospective, pilot, single center, open-label study in patients w...
Location
University of California, San Francisco
Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents
PHASE1This is a Phase I/II peptide receptor radiotherapy (PRRT) trial of 177Lu-DO...
Location
University of Iowa Hospitals and Clinics